Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSIF.L Regulatory News (SSIF)

  • There is currently no data for SSIF

Amendment and Termination of IMA

20 Aug 2021 07:00

RNS Number : 2427J
Secured Income Fund PLC
20 August 2021
Β 

20 August 2021

Β 

Secured Income Fund plc

Β 

LEI: 213800TR2S2TT6PKVH57

Β 

Β 

Amendment and Termination of Investment Management Agreement

Β 

The Board of Secured Income Fund plc (the "Company") announces that it has reached an agreement with its portfolio manager KKV Investment Management Ltd ("KKVIM") and its AIFM, Kvika Securities Limited ("KSL") to amend the investment management agreement dated 7 March 2017, as amended and novated, (the "IMA") between the Company, KKVIM and KSL and for the IMA to terminate with effect from midnight on 31 December 2021 (the "Agreement").

Β 

The key terms of the Agreement are set out below:

Β· Management fees payable by the Company to KKVIM of Β£20,500 per month from 1 August 2021 to 31 December 2021;

Β· A payment of Β£20,000 in total payable by the Company to KKVIM, but conditional on a senior employee providing continued services to the Company to 31 December 2021; and

Β· The IMA will terminate with effect from midnight on 31 December 2021. No party has the right to terminate the IMA prior to this date without cause. No fees shall be payable by either party on termination other than the amount referred to above.

Β 

The Board believes that the revised Agreement provides the Company with certainty over the level of future management fees payable to KKVIM with the added flexibility of facilitating the Company becoming self-managed should the Board deem that appropriate, whilst providing for the ongoing management of the portfolio to 31 December 2021. Overall, it allows for an orderly transition of the management of the portfolio to the Company. A further announcement regarding the ongoing management of the portfolio will be made in due course.

Β 

The Company also announces that the dispute between KKVIM and SQN Capital Management, LLC, as announced on 25 June 2021, has been settled.

Β 

This announcement contains inside information for the purposes of Article 7 of UK version of EU Regulation 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this announcement on behalf of the Company is Kevin Robins of Elysium Fund Management Limited.

Β 

For further information please contact:Β 

Β 

Directors

David Stevenson (Chair)

Susan Gaynor Coley

Brett Miller

Β 

Β 

Β 

tel: +44 7973 873785

tel: +44 7977 130673

tel: +44 7770 447338

Β 

Β 

KKV Investment Management Ltd

Catherine Halford Riera

Β 

Β 

Investor.communications@kkvim.comΒ 

finnCap Ltd.

Corporate Finance: William Marle

Sales: Mark Whitfeld

tel: +44 20 7220 0500

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGRPLMPTMTTBBAB
Date   Source Headline
2nd Aug 20238:19 amRNSDirector/PDMR Shareholding
1st Aug 202310:59 amRNSDirector/PDMR Shareholding
27th Jul 202312:00 pmRNSHolding(s) in Company
27th Jul 20239:45 amRNSDirector/PDMR Shareholding
25th Jul 202312:54 pmRNSNet Asset Value(s)
29th Jun 20237:00 amRNSB Share Scheme and Delisting
23rd Jun 20237:00 amRNSNet Asset Value(s)
30th May 20237:00 amRNSNet Asset Value(s)
22nd May 20234:45 pmRNSHolding(s) in Company
27th Apr 20237:00 amRNSNet Asset Value(s)
29th Mar 20234:35 pmRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNSNet Asset Value(s)
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20237:00 amRNSHalf-year Report
15th Mar 202310:45 amRNSCancellation of Capital Redemption Reserve
13th Mar 20232:05 pmRNSSecond Price Monitoring Extn
13th Mar 20232:00 pmRNSPrice Monitoring Extension
8th Mar 20232:05 pmRNSSecond Price Monitoring Extn
8th Mar 20232:00 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSNet Asset Value(s)
30th Jan 20239:21 amRNSNet Asset Value(s)
29th Dec 20228:18 amRNSNet Asset Value(s)
15th Dec 20223:51 pmRNSResult of AGM and GM
6th Dec 20225:39 pmRNSHolding(s) in Company
29th Nov 20228:36 amRNSNet Asset Value(s)
23rd Nov 20225:27 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSPublication of a circular
15th Nov 20227:00 amRNSNet Asset Value(s)
9th Nov 20221:24 pmRNSB Share Scheme
27th Sep 20228:48 amRNSNet Asset Value(s)
8th Sep 20224:00 pmRNSHolding(s) in Company
8th Sep 202210:00 amRNSAnnual Financial Report
2nd Sep 202212:00 pmRNSDividend Declaration
25th Aug 202210:00 amRNSNet Asset Value(s)
22nd Jul 20229:30 amRNSNet Asset Value(s)
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
29th Jun 20229:00 amRNSNet Asset Value(s)
6th Jun 20224:40 pmRNSSecond Price Monitoring Extn
6th Jun 20224:35 pmRNSPrice Monitoring Extension
6th Jun 20229:06 amRNSSecond Price Monitoring Extn
6th Jun 20229:00 amRNSPrice Monitoring Extension
26th May 20223:30 pmRNSB Share Scheme - Amendment
25th May 20224:53 pmRNSB Share Scheme
25th May 20229:00 amRNSNet Asset Value(s)
5th May 202212:00 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.